Literature DB >> 15834082

28,000 Cases of age related macular degeneration causing visual loss in people aged 75 years and above in the United Kingdom may be attributable to smoking.

J R Evans1, A E Fletcher, R P L Wormald.   

Abstract

BACKGROUND: Age related macular degeneration (AMD) causing visual impairment is common in older people. Previous studies have identified smoking as a risk factor for AMD. However, there is limited information for the older population in Britain.
METHODS: Population based cross sectional analytical study based in 49 practices selected to be representative of the population of Britain. Cases were people aged 75 years and above who were visually impaired (binocular acuity <6/18) as a result of AMD. Controls were people with normal vision (6/6 or better). Smoking history was ascertained using an interviewer administered questionnaire.
RESULTS: After controlling for potentially confounding factors, current smokers were twice as likely to have AMD compared to non-smokers (odds ratio 2.15, 95% CI 1.42 to 3.26). Ex-smokers were at intermediate risk (odds ratio 1.13, 0.86 to 1.47). People who stopped smoking more than 20 years previously were not at increased risk of AMD causing visual loss. Approximately 28,000 cases of AMD in older people in the United Kingdom may be attributable to smoking.
CONCLUSION: This is the largest study of the association of smoking and AMD in the British population. Smoking is associated with a twofold increased risk of developing AMD. An increased risk of AMD, which is the most commonly occurring cause of blindness in the United Kingdom, is yet another reason for people to stop smoking and governments to develop public health campaigns against this hazard.

Entities:  

Mesh:

Year:  2005        PMID: 15834082      PMCID: PMC1772624          DOI: 10.1136/bjo.2004.049726

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  23 in total

1.  Risk factors for age-related maculopathy: the Visual Impairment Project.

Authors:  C A McCarty; B N Mukesh; C L Fu; P Mitchell; J J Wang; H R Taylor
Journal:  Arch Ophthalmol       Date:  2001-10

Review 2.  Age related macular degeneration.

Authors:  Amresh Chopdar; Usha Chakravarthy; Dinesh Verma
Journal:  BMJ       Date:  2003-03-01

3.  Smoking and blindness.

Authors:  Simon P Kelly; Judith Thornton; Georgios Lyratzopoulos; Richard Edwards; Paul Mitchell
Journal:  BMJ       Date:  2004-03-06

Review 4.  Relation of smoking to the incidence of age-related maculopathy. The Beaver Dam Eye Study.

Authors:  R Klein; B E Klein; S E Moss
Journal:  Am J Epidemiol       Date:  1998-01-15       Impact factor: 4.897

Review 5.  How big is the burden of visual loss caused by age related macular degeneration in the United Kingdom?

Authors:  C G Owen; A E Fletcher; M Donoghue; A R Rudnicka
Journal:  Br J Ophthalmol       Date:  2003-03       Impact factor: 4.638

6.  Causes of visual impairment in people aged 75 years and older in Britain: an add-on study to the MRC Trial of Assessment and Management of Older People in the Community.

Authors:  J R Evans; A E Fletcher; R P L Wormald
Journal:  Br J Ophthalmol       Date:  2004-03       Impact factor: 4.638

7.  Glasgow Acuity Cards: a new test for the measurement of letter acuity in children.

Authors:  P V McGraw; B Winn
Journal:  Ophthalmic Physiol Opt       Date:  1993-10       Impact factor: 3.117

8.  Age-related macular degeneration causing visual impairment in people 75 years or older in Britain: an add-on study to the Medical Research Council Trial of Assessment and Management of Older People in the Community.

Authors:  Jennifer R Evans; Astrid E Fletcher; Richard P L Wormald
Journal:  Ophthalmology       Date:  2004-03       Impact factor: 12.079

9.  Smoking and the 5-year incidence of age-related maculopathy: the Blue Mountains Eye Study.

Authors:  Paul Mitchell; Jie Jin Wang; Wayne Smith; Stephen R Leeder
Journal:  Arch Ophthalmol       Date:  2002-10

10.  The MRC trial of assessment and management of older people in the community: objectives, design and interventions [ISRCTN23494848].

Authors:  A E Fletcher; D A Jones; C J Bulpitt; A J Tulloch
Journal:  BMC Health Serv Res       Date:  2002-10-25       Impact factor: 2.655

View more
  38 in total

1.  Synergic effect of polymorphisms in ERCC6 5' flanking region and complement factor H on age-related macular degeneration predisposition.

Authors:  Jingsheng Tuo; Baitang Ning; Christine M Bojanowski; Zhong-Ning Lin; Robert J Ross; George F Reed; Defen Shen; Xiaodong Jiao; Min Zhou; Emily Y Chew; Fred F Kadlubar; Chi-Chao Chan
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-05       Impact factor: 11.205

Review 2.  LOC387715/HTRA1 gene polymorphisms and susceptibility to age-related macular degeneration: A HuGE review and meta-analysis.

Authors:  Yu Tong; Jing Liao; Yuan Zhang; Jing Zhou; Hengyu Zhang; Meng Mao
Journal:  Mol Vis       Date:  2010-10-05       Impact factor: 2.367

3.  "Sight for more eyes".

Authors:  N Astbury
Journal:  Br J Ophthalmol       Date:  2006-05       Impact factor: 4.638

4.  Timely translation of ophthalmic research into clinical practice.

Authors:  C A McCarty
Journal:  Br J Ophthalmol       Date:  2006-09       Impact factor: 4.638

5.  Acute effects of cigarette smoking on pattern electroretinogram.

Authors:  Fatih C Gundogan; A Hakan Durukan; Tarkan Mumcuoglu; Gungor Sobaci; M Zeki Bayraktar
Journal:  Doc Ophthalmol       Date:  2006-09-14       Impact factor: 2.379

6.  The LOC387715 polymorphism and age-related macular degeneration: replication in three case-control samples.

Authors:  Robert J Ross; Christine M Bojanowski; Jie Jin Wang; Emily Y Chew; Elena Rochtchina; Frederick L Ferris; Paul Mitchell; Chi-Chao Chan; Jingsheng Tuo
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-03       Impact factor: 4.799

7.  [Age-related macular degeneration and risk of stroke].

Authors:  V Biousse; M-G Bousser; A Gaudric
Journal:  J Fr Ophtalmol       Date:  2008-01       Impact factor: 0.818

8.  Influence of TIMP3/SYN3 polymorphisms on the phenotypic presentation of age-related macular degeneration.

Authors:  Daniel Ardeljan; Catherine B Meyerle; Elvira Agron; Jie Jin Wang; Paul Mitchell; Emily Y Chew; Jing Zhao; Arvydas Maminishkis; Chi-Chao Chan; Jingsheng Tuo
Journal:  Eur J Hum Genet       Date:  2013-02-20       Impact factor: 4.246

9.  Metabolomic analysis of human disease and its application to the eye.

Authors:  Stephen P Young; Graham R Wallace
Journal:  J Ocul Biol Dis Infor       Date:  2009-11-13

10.  Toll-like receptor polymorphisms and age-related macular degeneration: replication in three case-control samples.

Authors:  Youngeun Cho; Jie Jin Wang; Emily Y Chew; Frederick L Ferris; Paul Mitchell; Chi-Chao Chan; Jingsheng Tuo
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-07-23       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.